Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Cyclophilin D Mediated Platelet Necrosis Regulates Ischemic Stroke Outcomes in Mice

Frederik Denorme, PhD, Bhanu Kanth Manne, PhD, Yasuhiro Kosaka, PhD, Benjamin Kile, PhD, Matthew T. Rondina, MD, Robert A. Campbell, PhD

Blood (2019) 134 (Supplement_1): 3620.

https://doi.org/10.1182/blood-2019-123839

Published: 2019

Journal Articles

Proteomic Discovery: Elevated Neurogranin Levels in Children with Sickle Cell Disease

Eboni I. Lance, MD, Lisa Faulcon, MD, Zongming Fu, PhD, Jun Yang, PhD, Donna Whyte, MD, John J. Strouse, MD, PhD, Emily Barron-Casella, PhD, Kimberly Jones, Jennifer Van Eck, PhD, James F. Casella, MD, Allen Everett, MD

Blood (2019) 134 (Supplement_1): 2296.

https://doi.org/10.1182/blood-2019-122015

Published: 2019

Journal Articles

Reduced Intensity Conditioning for Haploidentical Bone Marrow Transplantation in Patients with Symptomatic Sickle Cell Disease: BMT CTN Protocol 1507

Adetola A. Kassim, MDMS, Mark C. Walters, MD, Mary Eapen, MBBS, MS, Brianne Allison, MS, Adam M. Mendizabal, MS, Robert A. Brodsky, MD, Michael R. DeBaun, MDMPH

Blood (2019) 134 (Supplement_1): 802.

https://doi.org/10.1182/blood-2019-126321

Published: 2019

Journal Articles

SOD3-Mimetic As a Complement for Genetic Therapy in Sickle Cell Disease

Carleton JC Hsia, PhD, Li Ma, PhD

Blood (2018) 132 (Supplement 1): 2355.

https://doi.org/10.1182/blood-2018-99-120287

Published: 2018

Journal Articles

Results from Part A of the Hemoglobin Oxygen Affinity Modulation to Inhibit HbS Polymerization (HOPE) Trial (GBT440-031), a Placebo-Controlled Randomized Study Evaluating Voxelotor (GBT440) in Adults and Adolescents with Sickle Cell Disease

Blood (2018) 132 (Supplement 1): 505.

https://doi.org/10.1182/blood-2018-99-118508

Published: 2018

Journal Articles

Allogenic C57B/6->B6D2F1 Transplantation As a Model for Graft Versus Host Disease in the Brain

Sarah Bryant, BS, Ian Moore, PhD, Bianca Nagata, Danielle Springer, VMD, DACLAM, Audrey Noguchi, Morteza Peiravi, Karlie Sharma, PhD, Sherry M. Koontz, Harry Malech, MD, Elizabeth Kang, MD

Blood (2017) 130 (Supplement 1): 3172.

https://doi.org/10.1182/blood.V130.Suppl_1.3172.3172

Published: 2017

Journal Articles

Disease and Therapy Associated Complications of the Central Nervous System after Allogeneic Hematopoietic Cell Transplantation - a Significant Proportion of Patients Will Suffer from Permanent Damage

Sebastian P. Haen, MD, Manfred Zierhut, MD, Nora Mirza, PhD, Christoph M. Simon, MD, Andreas Korn, MD, Christoph Faul, MD, Wichard Vogel, MD, Hans-Georg Rammensee, PhD, Lothar Kanz, MD, Wolfgang Bethge, MD

Blood (2016) 128 (22): 4620.

https://doi.org/10.1182/blood.V128.22.4620.4620

Published: 2016

Journal Articles

Incidence of Neurological Complications Secondary to Intrathecal Chemotherapy Used As Either Prophylaxis or Treatment of Leptomeningeal Carcinomatosis

Diana M Byrnes, MD MPH, Christopher R Dermarkarian, BS, Ryan Kahn, BA, MHS, Deukwoo Kwon, PhD, Fernando Vargas, MD, Judith Hurley, MD, Justin M. Watts, MD, Jonathan H. Schatz, MD, Ronan T Swords, MD PhD FRCPI, FRCPath

Blood (2016) 128 (22): 5973.

https://doi.org/10.1182/blood.V128.22.5973.5973

Published: 2016

Journal Articles

Quantitative MRI of Hemodynamic Compromise in Children with Sickle Cell Disease: New Insights into Pathophysiology

Paula L Croal, PhD, Malambing G Serafin, Przemyslaw Kosinski, BSc, Jackie Leung, MASc, Suzan Williams, MD, Andrea Kassner, PhD

Blood (2015) 126 (23): 2168.

https://doi.org/10.1182/blood.V126.23.2168.2168

Published: 2015

Journal Articles

Progressive Loss of Brain Volume in Children with Sickle Cell Anemia: A Report from the Silent Cerebral Infarct Transfusion Trial Cohort

Odianosen Eigbire-Molen, Deepika S. Darbari, MD, Maria R. Ponisio, MD, Mikhail V. Milchenko, PhD, Mark J. Rodeghier, PhD, James F. Casella, MD, Robert McKinstry, MD PhD, Michael R. DeBaun, MD MPH

Blood (2015) 126 (23): 546.

https://doi.org/10.1182/blood.V126.23.546.546

Published: 2015

Journal Articles

Parvovirus B19 Infection Associated with Silent Cerebral Infarcts: A Secondary Analysis of the Silent Cerebral Infarct Trial Cohort

Foluso Joy Ogunsile, MD, Michael R. DeBaun, MD MPH, Kelli Currie, Mark J. Rodeghier, PhD

Blood (2015) 126 (23): 3410.

https://doi.org/10.1182/blood.V126.23.3410.3410

Published: 2015

Journal Articles

Headache Prevalence Following Recovery from TTP and aHUS: A Single-Center, Cross Sectional Cohort Survey Study

Jennifer N Saultz, DO, Haifeng M Wu, MD, Spero R Cataland, MD

Blood (2014) 124 (21): 4826.

https://doi.org/10.1182/blood.V124.21.4826.4826

Published: 2014

Journal Articles

Quantitation of Iron in Brain Structures of Children with Sickle Cell Disease and Transfusion Hemosiderosis

R. Clark Brown, MD PhD, Deqiang Qiu, PhD, Laura Hayes, MD, Vaughn Barry, PhD MPH, Richard Jones, PhD

Blood (2014) 124 (21): 1393.

https://doi.org/10.1182/blood.V124.21.1393.1393

Published: 2014

Journal Articles

Silent Cerebral Infarcts and Cerebral Aneurysms Are Prevalent in Adults with Sickle Cell Disease

Adetola A. Kassim, MD, Sumit Pruthi, MD, Matthew Day, MD, Michael R. DeBaun, MD MPH, Lori C. Jordan, MD

Blood (2014) 124 (21): 2712.

https://doi.org/10.1182/blood.V124.21.2712.2712

Published: 2014

Journal Articles

Encephaloduroarteriosynangiosis (EDAS) For Patients With Sickle Cell Disease

Jeffrey D. Lebensburger, DO, Christina J. Bemrich-Stolz, MD, Christoph Griessenauer, MD, Lee Hilliard, MD, Thomas H. Howard, MD, Michael R. DeBaun, MD, MPH, James M. Johnston, MD

Blood (2013) 122 (21): 999.

https://doi.org/10.1182/blood.V122.21.999.999

Published: 2013

Journal Articles

Clinical-Scale Expansion of Human Bone Marrow-Derived Mesenchymal Stromal Cells to Treat Patients After Ischemic Stroke.

Patrick J Hanley, PhD, Zhuyong Mei, MD, Bing Yang, MD, Osman Mir, MD, Kaushik Parsha, MD, April Durett, R. Brent Rice, PhD, Maria G Cabreira-Hansen, PhD, Sean I Savitz, MD, Adrian P. Gee, PhD

Blood (2012) 120 (21): 3021.

https://doi.org/10.1182/blood.V120.21.3021.3021

Published: 2012

Journal Articles

Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia

Michael R. DeBaun, F. Daniel Armstrong, Robert C. McKinstry, Russell E. Ware, Elliot Vichinsky, Fenella J. Kirkham

Blood (2012) 119 (20): 4587–4596.

https://doi.org/10.1182/blood-2011-02-272682

Published: 2012

Journal Articles

High Mortality In Extreme Hyperleukocytosis In Pediatric Acute Myeloid Leukemia: A Report From the Children's Oncology Group.

Lillian Sung, MD, PhD, Todd A. Alonzo, PhD, Robert B. Gerbing, MS, Richard Aplenc, MD, MSCE, Soheil Meshinchi, MD, PhD, Laura Burden, CCRP, Susana C. Raimondi, PhD, Betsy A. Hirsch, PhD, Samir Kahwash, MD, Amy Heerema-McKenney, MD, Laura Winter, PharmD, Kathleen Glick, BA, CCRP, Patti Byron, MSN, RN, Tanya Wallas, MS, Franklin O. Smith, MD, Alan S. Gamis, MD, MPH

Blood (2010) 116 (21): 1072.

https://doi.org/10.1182/blood.V116.21.1072.1072

Published: 2010

Journal Articles

Catastrophic NAD + Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE.

Santina Bruzzone, Ph.D., Floriana Fruscione, Sara Morando, Alessandro Poggi, Anna Garuti, Martina Selmo, Tiziana Ferrando, Federica Benvenuto, Michele Cea, MD, Debora Soncini, Eva Moran, Ph.D., Ilaria Rocco, Gabriella Cirmena, Gabriele Zoppoli, MD, Alberto Ballestrero, MD, Ph.D., Bernard Sordat, Franco Patrone, Antonio Uccelli, Alessio Nencioni, MD, Ph.D.

Blood (2009) 114 (22): 4732.

https://doi.org/10.1182/blood.V114.22.4732.4732

Published: 2009

Journal Articles

Elevated Systolic Blood Pressure and Low Fetal Hemoglobin Are Risk Factors for Silent Cerebral Infarcts in Children with Sickle Cell Anemia.

Blood (2009) 114 (22): 262.

https://doi.org/10.1182/blood.V114.22.262.262

Published: 2009

NARROW

Cyclophilin D Mediated Platelet Necrosis Regulates Ischemic Stroke Outcomes in Mice

Proteomic Discovery: Elevated Neurogranin Levels in Children with Sickle Cell Disease

Reduced Intensity Conditioning for Haploidentical Bone Marrow Transplantation in Patients with Symptomatic Sickle Cell Disease: BMT CTN Protocol 1507

SOD3-Mimetic As a Complement for Genetic Therapy in Sickle Cell Disease

Results from Part A of the Hemoglobin Oxygen Affinity Modulation to Inhibit HbS Polymerization (HOPE) Trial (GBT440-031), a Placebo-Controlled Randomized Study Evaluating Voxelotor (GBT440) in Adults and Adolescents with Sickle Cell Disease

Allogenic C57B/6->B6D2F1 Transplantation As a Model for Graft Versus Host Disease in the Brain

Disease and Therapy Associated Complications of the Central Nervous System after Allogeneic Hematopoietic Cell Transplantation - a Significant Proportion of Patients Will Suffer from Permanent Damage

Incidence of Neurological Complications Secondary to Intrathecal Chemotherapy Used As Either Prophylaxis or Treatment of Leptomeningeal Carcinomatosis

Quantitative MRI of Hemodynamic Compromise in Children with Sickle Cell Disease: New Insights into Pathophysiology

Progressive Loss of Brain Volume in Children with Sickle Cell Anemia: A Report from the Silent Cerebral Infarct Transfusion Trial Cohort

Parvovirus B19 Infection Associated with Silent Cerebral Infarcts: A Secondary Analysis of the Silent Cerebral Infarct Trial Cohort

Headache Prevalence Following Recovery from TTP and aHUS: A Single-Center, Cross Sectional Cohort Survey Study

Quantitation of Iron in Brain Structures of Children with Sickle Cell Disease and Transfusion Hemosiderosis

Silent Cerebral Infarcts and Cerebral Aneurysms Are Prevalent in Adults with Sickle Cell Disease

Encephaloduroarteriosynangiosis (EDAS) For Patients With Sickle Cell Disease

Clinical-Scale Expansion of Human Bone Marrow-Derived Mesenchymal Stromal Cells to Treat Patients After Ischemic Stroke.

Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia

High Mortality In Extreme Hyperleukocytosis In Pediatric Acute Myeloid Leukemia: A Report From the Children's Oncology Group.

Catastrophic NAD + Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE.

Elevated Systolic Blood Pressure and Low Fetal Hemoglobin Are Risk Factors for Silent Cerebral Infarcts in Children with Sickle Cell Anemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only